Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial—results from the Scleroderma Lung Study

Objective. Scleroderma Lung Study (SLS) showed that cyclophosphamide (CYC) was better than placebo (PLA) in preventing progression of forced vital capacity percentage (FVC%) predicted and dyspnoea at 12 months. Our objective was to assess minimally important difference (MID) for Mahler's Transi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khanna, Dinesh, Tseng, Chi-Hong, Furst, Daniel E., Clements, Philip J., Elashoff, Robert, Roth, Michael, Elashoff, David, Tashkin, Donald P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2009
Témata:
Clinical
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2777487/
https://ncbi.nlm.nih.gov/pubmed/19776222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kep284
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky